SSM Health reached a settlement with pension plan participants legally challenging the non-for-profit corporation's church plan status, according to court documents filed Monday in U.S. District Court in St. Louis.
Democratic candidates in state attorney general races have leveraged their party's national campaign strategy around coverage of pre-existing conditions. They're trying to beat Republican incumbents who are suing to end Obamacare.
Opponents of the new short-term limited duration rule were dealt a setback in a federal court Friday as a U.S. district judge urged insurers suing the Trump administration to wait for proof it is harming the ACA markets.
State-contracted providers and insurers may pay executives more than $199,000 a year as long as they are not using state funds, according to a recent ruling from New York's highest court.
Under the agreement, the University of Southern California will pay $2,500 to $250,000 to each of the approximately 500 women who claimed abuse by Dr. George Tyndall between 1988 and 2016.
New York physicians who are members of the malpractice insurer MLMIC have a new backer as they fight lawsuits from patients: billionaire Warren Buffett.
The four men and their companies were indicted for attempting to defraud insurers by overbilling for various prescriptions.
A federal lawsuit contends the operators of a North Carolina drug rehab program farmed out recovering addicts to work in adult care homes and restaurants and pocketed the wages for the labor they performed.
The HHS vs. providers' billion-dollar fight over Medicare will head to the Supreme Court this term.
Maryland's attorney general has filed a lawsuit against the Trump administration for efforts he says are intended to undercut the nation's healthcare law.
A federal judge's recent decision to vacate the 2014 Medicare Advantage overpayment rule paves the way for insurers to continue upcoding to reap higher CMS payments that could cost billions of dollars, experts said.
Hospital groups sued HHS Secretary Alex Azar over the delay in setting the ceiling price that 340B providers have to pay drugmakers.